Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Glycemic Control in Gestational Diabetes Mellitus
NCT07369284Phase 2Not yet recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of melatonin in gestational diabetes mellitus (GDM), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT07369284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07369284.